Floral expression and pollen germination ability in productive mountain papaya ( Vasconcellea pubescens A.DC.) orchards

Mountain papaya ( Vasconcellea pubescens A.DC.) is described as trioecious in the centers of origin of Ecuador, Colombia, and Peru. However, under cultivation conditions in La Serena (30° S, 70° W), Chile, it is found to be dioecious and monoecious. The objective was to learn about the variations in floral expression of mountain papaya. Flowers from monoecious and dioecious plants were therefore identified and quantified during two seasons. In vitro pollen germination ability was also evaluated based on the factors of site, season, and plant sex. Monoecious plant inflorescences are polygamous; female and male flowers are observed, as well as bisexual flowers that are usually deformed. This condition allows them to be classified as an ambisexual plant. The existence of flowers of different sexes appears to depend on the season; the female dioecious plant is maintained as such, independently of climatic conditions. Pollen from male flowers, from both ambisexual and male plants, germinates 75% in summer, while germination decreases to 56% in spring (P ≤ 0.05). Flowering of female plants coincides with the permanent occurrence of male flowers in ambisexual plants, which ensures pollination without the need for male plants as pollinators in orchards. Based on this information, some management practices and possible lines of research about this species are proposed.

EVALUATION OF THE ANTI-FUNGAL PROPERTIES OF EXTRACTS OF Daniella oliveri

The in vitro anti-fungal activity of leaf and stem bark of Daniella oliveri Rolfe was investigated against selected yeasts and moulds including dermatophytes. Water and methanol were used to extract the powdered leaf and stem bark using cold infusion. Antimicrobial activity was assessed by agar-well diffusion. Phytochemical analysis was carried out using standard procedures. The plant extracts were active against the test organisms at concentrations ranging from 3.125-100 mg/mL. The methanol extracts were more active than the aqueous extracts with the highest inhibition against the yeasts, Candida albicans and Candida krusei (MIC values of 3.125 mg/mL and 6.25 mg/mL respectively). Epidermophyton floccosum and Trichophyton interdigitale were the least inhibited of all the fungal strains. Phytochemical screening revealed the presence of tannins, anthraquinones, flavonoids, cardiac glycosides, alkaloids and saponins. The anti-fungal activity of Daniella oliveri as shown in this study indicates that the plant has the potential of utilisation in the development of chemotherapeutic agents for the treatment of relevant fungal infections.

New insights on the development of fungal vaccines: from immunity to recent challenges

Fungal infections are emerging as a major problem in part due to high mortality associated with systemic infections, especially in the case of immunocompromised patients. With the development of new treatments for diseases such as cancer and the acquired immune deficiency syndrome pandemic, the number of immunosuppressed patients has increased and, as a consequence, also the number of invasive fungal infections has increased. Several studies have proposed new strategies for the development of effective fungal vaccines. In addition, better understanding of how the immune system works against fungal pathogens has improved the further development of these new vaccination strategies. As a result, some fungal vaccines have advanced through clinical trials. However, there are still many challenges that prevent the clinical development of fungal vaccines that can efficiently immunise subjects at risk of developing invasive fungal infections. In this review, we will discuss these new vaccination strategies and the challenges that they present. In the future with proper investments, fungal vaccines may soon become a reality.